Index S&P 500 P/E 29.03 EPS (ttm) 3.23 Insider Own 4.11% Shs Outstand 246.40M Perf Week 0.06%
Market Cap 23.17B Forward P/E 26.12 EPS next Y 3.59 Insider Trans -0.09% Shs Float 236.69M Perf Month 7.56%
Income 798.00M PEG 4.45 EPS next Q 0.79 Inst Own 89.06% Short Float 0.72% Perf Quarter 22.22%
Sales 5.04B P/S 4.59 EPS this Y 4.26% Inst Trans - Short Ratio 1.01 Perf Half Y 36.01%
Book/sh 6.00 P/B 15.63 EPS next Y 8.04% ROA 15.12% Short Interest 1.71M Perf Year -
Cash/sh 3.35 P/C 28.01 EPS next 5Y 6.52% ROE 33.08% 52W Range 65.51 - 95.56 Perf YTD 14.09%
Dividend Est. 0.30 (0.32%) P/FCF 26.81 EPS past 5Y - ROI 19.46% 52W High -1.79% Beta -
Dividend TTM 0.18 (0.19%) Quick Ratio 1.56 Sales past 5Y 4.94% Gross Margin 57.38% 52W Low 43.26% ATR (14) 2.17
Dividend Ex-Date Mar 27, 2024 Current Ratio 1.83 EPS Y/Y TTM -10.43% Oper. Margin 22.63% RSI (14) 61.74 Volatility 1.88% 2.43%
Employees 16000 Debt/Eq 1.88 Sales Y/Y TTM 2.42% Profit Margin 15.83% Recom 1.92 Target Price 98.30
Option/Short Yes / Yes LT Debt/Eq 1.77 EPS Q/Q -19.11% Payout 2.64% Rel Volume 0.75 Prev Close 94.38
Sales Surprise 1.65% EPS Surprise 10.01% Sales Q/Q 1.71% Earnings Apr 23 AMC Avg Volume 1.69M Price 93.85
SMA20 3.65% SMA50 5.48% SMA200 16.50% Trades
Volume 1,265,861 Change -0.56%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-22-24 Initiated Goldman
Buy
$104
Mar-12-24 Initiated Exane BNP Paribas
Outperform
$103
Feb-27-24 Initiated BMO Capital Markets
Outperform
$97
Jan-10-24 Initiated Deutsche Bank
Hold
$79
Jan-09-24 Initiated Argus
Buy
$90
Dec-13-23 Initiated Wolfe Research
Peer Perform
Nov-30-23 Initiated Stifel
Buy
$82
Nov-03-23 Initiated RBC Capital Mkts
Sector Perform
$78
Oct-16-23 Upgrade Vertical Research
Hold → Buy
$82
Oct-06-23 Initiated Citigroup
Neutral
$87
Oct-03-23 Initiated Melius
Overweight
$108
Sep-29-23 Initiated Robert W. Baird
Neutral
$82
Show Previous Ratings
Apr-25-24 03:06AM
Apr-23-24 08:53PM
04:30PM
Apr-03-24 08:30AM
Mar-27-24 11:35AM
08:00AM
Loading…
Mar-08-24 08:00AM
Feb-27-24 04:24PM
Feb-26-24 08:00AM
Feb-15-24 09:15AM
Feb-13-24 05:30AM
Feb-08-24 08:48AM
Feb-06-24 04:30PM
Feb-02-24 05:47AM
Jan-18-24 08:00AM
Jan-09-24 10:00AM
08:30AM
Loading…
Dec-20-23 08:30AM
Nov-29-23 06:15PM
Nov-03-23 09:00AM
Oct-25-23 05:15PM
Oct-12-23 09:00AM
Oct-03-23 04:22PM
(Yahoo Finance Video) -9.48%
Oct-02-23 04:27PM
04:11PM
Veralto Corp. engages in the provision of environmental and applied solutions. Its segments include Water Quality and Product Quality & Innovation. The Water Quality segment provides comprehensive portfolios of water analytics and differentiated water treatment solutions that enable the reliable delivery of safe drinking water by public and private utilities. The Product Quality & Innovation segment provides a broad set of solutions for brand owners and consumer packaged goods companies that enable speed to market as well as traceability and quality control of their products. The company was founded on October 26, 2022 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Aquino Melissa SVP, Water Quality Apr 26 '24 Sale 93.56 8,041 752,316 20,761 Apr 29 04:34 PM Bystrom Mattias Group Executive, Product ID Feb 16 '24 Sale 86.10 500 43,050 30,310 Feb 20 07:40 PM MITTS HEATH A Director Feb 02 '24 Buy 76.46 9 688 831 Feb 06 09:15 PM Beneteau Lesley SVP, CHRO Nov 01 '23 Option Exercise 18.36 1,780 32,681 11,133 Nov 03 04:36 PM Aquino Melissa VP, Group Exec Water Quality Nov 01 '23 Option Exercise 67.51 199 13,462 29,587 Nov 17 05:27 PM Aquino Melissa VP, Group Exec Water Quality Nov 01 '23 Sale 67.51 199 13,462 29,388 Nov 17 05:27 PM
Index S&P 500 P/E 41.85 EPS (ttm) 5.90 Insider Own 8.82% Shs Outstand 739.20M Perf Week 0.42%
Market Cap 182.83B Forward P/E 28.49 EPS next Y 8.66 Insider Trans -0.16% Shs Float 675.38M Perf Month 1.02%
Income 4.40B PEG 5.56 EPS next Q 1.59 Inst Own 81.81% Short Float 0.92% Perf Quarter 0.70%
Sales 26.23B P/S 6.97 EPS this Y 0.26% Inst Trans -0.21% Short Ratio 2.38 Perf Half Y 28.55%
Book/sh 72.16 P/B 3.42 EPS next Y 13.99% ROA 5.28% Short Interest 6.20M Perf Year 14.70%
Cash/sh 9.49 P/C 26.00 EPS next 5Y 7.52% ROE 8.47% 52W Range 182.09 - 259.00 Perf YTD 6.70%
Dividend Est. 0.96 (0.39%) P/FCF 32.90 EPS past 5Y 11.31% ROI 6.30% 52W High -4.69% Beta 0.86
Dividend TTM 1.05 (0.43%) Quick Ratio 1.51 Sales past 5Y 8.35% Gross Margin 58.35% 52W Low 35.56% ATR (14) 5.29
Dividend Ex-Date Mar 27, 2024 Current Ratio 1.85 EPS Y/Y TTM -36.66% Oper. Margin 21.32% RSI (14) 52.20 Volatility 1.81% 1.86%
Employees 63000 Debt/Eq 0.36 Sales Y/Y TTM -15.25% Profit Margin 16.78% Recom 1.65 Target Price 274.37
Option/Short Yes / Yes LT Debt/Eq 0.31 EPS Q/Q -25.02% Payout 16.45% Rel Volume 1.05 Prev Close 246.89
Sales Surprise 3.09% EPS Surprise 11.84% Sales Q/Q -19.13% Earnings Apr 23 BMO Avg Volume 2.61M Price 246.84
SMA20 1.30% SMA50 -0.75% SMA200 7.66% Trades
Volume 2,732,387 Change -0.02%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-17-24 Upgrade HSBC Securities
Hold → Buy
$280
Jan-24-24 Downgrade Barclays
Overweight → Equal Weight
$240
Dec-18-23 Initiated HSBC Securities
Hold
Dec-13-23 Resumed Wolfe Research
Peer Perform
Dec-07-23 Downgrade Goldman
Buy → Neutral
$215 → $205
Jul-19-23 Initiated Raymond James
Outperform
$270
May-01-23 Initiated SVB Securities
Outperform
$300
Apr-26-23 Downgrade BofA Securities
Buy → Neutral
$310 → $250
Apr-18-23 Upgrade Wells Fargo
Equal Weight → Overweight
$275 → $285
Jan-05-23 Downgrade Credit Suisse
Outperform → Neutral
$315 → $300
Dec-14-22 Initiated Deutsche Bank
Buy
$310
Oct-24-22 Downgrade The Benchmark Company
Buy → Hold
$325
Aug-25-22 Initiated Credit Suisse
Outperform
$340
Aug-17-22 Resumed Bernstein
Outperform
$330 → $340
Jul-20-22 Initiated UBS
Buy
$297
Jun-01-22 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$299 → $310
Apr-25-22 Downgrade Wells Fargo
Overweight → Equal Weight
$265
Jan-11-22 Initiated Bernstein
Outperform
$365
Oct-15-21 Resumed Cowen
Outperform
$350
Sep-10-21 Reiterated BofA Securities
Buy
$340 → $360
Show Previous Ratings
May-01-24 08:00AM
Apr-26-24 03:09PM
Apr-25-24 07:00PM
Apr-24-24 09:52AM
03:01AM
01:02AM
Loading…
01:02AM
Apr-23-24 10:17PM
(Thomson Reuters StreetEvents) +7.21%
04:41PM
12:21PM
(The Wall Street Journal)
12:07PM
(Associated Press Finance)
11:39AM
11:33AM
(Investor's Business Daily)
11:29AM
10:53AM
10:44AM
09:30AM
Loading…
09:30AM
07:31AM
07:10AM
06:59AM
06:55AM
06:26AM
06:07AM
(Associated Press Finance)
06:00AM
05:37AM
Apr-19-24 09:52AM
Apr-18-24 04:27PM
12:10PM
10:58AM
09:15AM
Apr-17-24 08:00AM
12:16PM
Loading…
Apr-13-24 12:16PM
Apr-12-24 12:30PM
Apr-11-24 04:30PM
12:19PM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
08:00AM
Apr-02-24 06:15PM
Mar-28-24 03:41AM
Mar-27-24 06:00PM
09:30AM
08:00AM
Mar-26-24 06:15PM
Mar-21-24 04:15PM
10:25AM
09:00AM
Mar-20-24 06:00PM
08:00AM
Mar-18-24 06:15PM
Mar-13-24 10:23AM
08:05AM
Mar-12-24 06:00PM
Mar-11-24 06:15PM
Mar-06-24 06:00AM
Mar-05-24 06:00PM
Mar-04-24 09:06AM
Mar-02-24 10:42AM
Mar-01-24 09:00AM
Feb-29-24 11:30AM
Feb-28-24 06:00PM
Feb-27-24 04:15PM
Feb-25-24 02:38PM
Feb-22-24 09:01PM
04:15PM
Feb-21-24 04:15PM
Feb-17-24 01:28PM
Feb-12-24 03:03PM
Feb-09-24 01:40AM
Feb-05-24 07:30AM
Feb-01-24 11:08AM
Jan-30-24 11:14PM
(Thomson Reuters StreetEvents)
01:26PM
11:44AM
11:08AM
09:30AM
07:10AM
06:34AM
06:17AM
(Associated Press Finance)
06:00AM
Jan-29-24 12:56PM
08:36AM
07:30AM
Jan-26-24 08:10AM
Jan-25-24 09:15AM
Jan-23-24 10:00AM
Jan-22-24 06:00PM
Jan-19-24 04:27AM
Jan-17-24 12:10PM
Jan-16-24 06:15PM
Jan-10-24 06:00PM
Jan-09-24 06:15PM
09:19AM
07:30AM
Jan-08-24 04:15PM
Jan-03-24 06:00PM
Jan-02-24 06:15PM
05:00PM
Dec-27-23 06:15PM
Dec-25-23 08:14PM
Dec-21-23 04:30PM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weidemanis Joakim Executive Vice President Apr 25 '24 Option Exercise 58.48 22,433 1,311,882 112,845 Apr 26 05:00 PM Weidemanis Joakim Executive Vice President Apr 25 '24 Sale 250.46 22,433 5,618,569 90,412 Apr 26 05:00 PM Blair Rainer President & CEO Apr 24 '24 Option Exercise 59.91 38,170 2,286,870 154,165 Apr 25 05:00 PM Blair Rainer President & CEO Apr 24 '24 Sale 249.22 47,175 11,756,725 115,995 Apr 25 05:00 PM Ellis Brian W Senior Vice President - GC Apr 24 '24 Sale 250.01 4,000 1,000,040 29,830 Apr 25 05:00 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Option Exercise 58.48 23,757 1,389,309 61,859 Feb 27 05:01 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Sale 252.00 23,757 5,986,764 38,102 Feb 27 05:01 PM LOHR WALTER G Director Feb 15 '24 Option Exercise 52.56 3,289 172,870 17,418 Feb 16 05:01 PM LOHR WALTER G Director Feb 15 '24 Sale 251.15 3,289 826,032 14,129 Feb 16 05:01 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Option Exercise 70.71 2,622 185,414 6,022 Feb 14 05:00 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Sale 242.67 2,622 636,290 4,244 Feb 14 05:00 PM List Teri Director Feb 06 '24 Option Exercise 52.56 3,289 172,870 23,015 Feb 08 05:00 PM List Teri Director Feb 06 '24 Sale 248.32 3,289 816,724 19,726 Feb 08 05:00 PM Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer Aug 21 '23 Sale 250.54 590 147,819 6,939 Aug 22 05:00 PM Raskas Daniel SVP - Corporate Development Jul 28 '23 Option Exercise 56.70 11,213 635,777 49,501 Aug 01 05:03 PM Zerhouni Elias A. Director Jul 28 '23 Option Exercise 50.80 3,490 177,292 30,523 Aug 01 05:02 PM SCHWIETERS JOHN T Director Jul 28 '23 Option Exercise 50.80 3,490 177,292 22,583 Aug 01 05:02 PM FILLER LINDA Director Jul 28 '23 Option Exercise 59.17 2,922 172,895 41,074 Aug 01 05:00 PM Raskas Daniel SVP - Corporate Development Jul 28 '23 Sale 260.65 11,213 2,922,652 38,288 Aug 01 05:03 PM FILLER LINDA Director Jul 28 '23 Sale 260.25 10,190 2,651,978 38,152 Aug 01 05:00 PM Weidemanis Joakim Executive Vice President Jul 26 '23 Option Exercise 56.70 22,439 1,272,291 111,128 Jul 27 05:01 PM List Teri Director Jul 26 '23 Option Exercise 50.80 3,490 177,292 20,984 Jul 27 05:00 PM Weidemanis Joakim Executive Vice President Jul 26 '23 Sale 263.42 22,439 5,910,832 88,689 Jul 27 05:01 PM List Teri Director Jul 26 '23 Sale 263.30 3,490 918,917 17,494 Jul 27 05:00 PM Raskas Daniel SVP - Corporate Development May 31 '23 Option Exercise 57.90 19,847 1,149,141 58,520 Jun 01 05:00 PM Raskas Daniel SVP - Corporate Development May 31 '23 Sale 228.50 19,847 4,535,040 38,673 Jun 01 05:00 PM LOHR WALTER G Director May 05 '23 Option Exercise 50.80 3,490 177,292 15,605 May 08 05:08 PM LOHR WALTER G Director May 05 '23 Sale 240.88 3,490 840,685 12,115 May 08 05:08 PM Weidemanis Joakim Executive Vice President May 04 '23 Option Exercise 57.90 9,934 575,179 101,357 May 05 05:01 PM Weidemanis Joakim Executive Vice President May 04 '23 Sale 245.27 9,934 2,436,512 91,423 May 05 05:01 PM Couchara Georgeann SVP, Human Resources May 04 '23 Sale 245.27 695 170,463 1,565 May 05 05:00 PM
Index - P/E - EPS (ttm) -1.69 Insider Own 44.48% Shs Outstand 361.33M Perf Week -11.05%
Market Cap 14.58B Forward P/E 9.03 EPS next Y 4.49 Insider Trans -0.18% Shs Float 199.46M Perf Month -13.42%
Income -608.40M PEG - EPS next Q 0.90 Inst Own 60.50% Short Float 7.77% Perf Quarter 0.00%
Sales 3.25B P/S 4.49 EPS this Y 21.18% Inst Trans 2.14% Short Ratio 6.50 Perf Half Y 47.35%
Book/sh 14.37 P/B 2.82 EPS next Y 14.41% ROA -2.86% Short Interest 15.50M Perf Year 38.97%
Cash/sh 4.98 P/C 8.15 EPS next 5Y 13.49% ROE -10.66% 52W Range 25.20 - 48.52 Perf YTD -0.27%
Dividend Est. 1.41 (3.47%) P/FCF 16.66 EPS past 5Y - ROI -4.35% 52W High -16.36% Beta 1.80
Dividend TTM 1.40 (3.45%) Quick Ratio - Sales past 5Y 26.65% Gross Margin 47.58% 52W Low 61.03% ATR (14) 1.38
Dividend Ex-Date Feb 22, 2024 Current Ratio - EPS Y/Y TTM -149.61% Oper. Margin -14.25% RSI (14) 28.57 Volatility 3.22% 2.76%
Employees 2200 Debt/Eq 1.78 Sales Y/Y TTM -31.95% Profit Margin -18.72% Recom 2.33 Target Price 49.60
Option/Short Yes / Yes LT Debt/Eq 1.69 EPS Q/Q -652.74% Payout - Rel Volume 1.30 Prev Close 40.97
Sales Surprise 1.42% EPS Surprise 4.49% Sales Q/Q 14.98% Earnings May 02 BMO Avg Volume 2.38M Price 40.58
SMA20 -11.16% SMA50 -11.52% SMA200 8.69% Trades
Volume 3,099,294 Change -0.95%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-19-24 Downgrade Citigroup
Buy → Neutral
$40 → $41
Jan-04-24 Initiated TD Cowen
Market Perform
$42
Nov-29-23 Downgrade Evercore ISI
Outperform → In-line
$32
Oct-05-23 Initiated Wolfe Research
Peer Perform
May-19-23 Initiated Citigroup
Buy
$40
Mar-02-23 Initiated Barclays
Overweight
$41
Jan-03-23 Downgrade Keefe Bruyette
Outperform → Mkt Perform
$36
Oct-19-22 Initiated Credit Suisse
Outperform
$38.50
Sep-06-22 Downgrade BofA Securities
Buy → Underperform
$58 → $33
Aug-09-22 Downgrade Jefferies
Buy → Hold
$55 → $38
Jul-29-22 Upgrade Evercore ISI
In-line → Outperform
$38 → $45
Jun-08-22 Initiated JMP Securities
Mkt Outperform
$60
Dec-16-21 Initiated BofA Securities
Buy
$79
Sep-13-21 Upgrade BMO Capital Markets
Market Perform → Outperform
$59 → $65
Aug-11-21 Upgrade Deutsche Bank
Hold → Buy
$53 → $58
Feb-19-21 Upgrade Credit Suisse
Neutral → Outperform
$40 → $42
Jan-19-21 Upgrade Keefe Bruyette
Mkt Perform → Outperform
$40
Nov-20-20 Upgrade BofA Securities
Underperform → Buy
$30 → $35
Oct-12-20 Upgrade Citigroup
Neutral → Buy
Jun-08-20 Downgrade Citigroup
Buy → Neutral
Show Previous Ratings
May-02-24 12:54PM
11:25AM
11:00AM
10:00AM
08:58AM
03:07AM
Loading…
03:07AM
May-01-24 10:45PM
(Thomson Reuters StreetEvents) -8.55%
08:19PM
01:07PM
12:00PM
(The Wall Street Journal)
11:55AM
11:45AM
11:30AM
08:23AM
07:49AM
(Associated Press Finance)
07:31AM
Loading…
07:31AM
06:15AM
Apr-30-24 04:05PM
03:00PM
12:40PM
10:32AM
09:15AM
Apr-29-24 05:25PM
Apr-26-24 01:10PM
12:59PM
Apr-24-24 02:29PM
01:31PM
Apr-23-24 04:19PM
Apr-22-24 03:01PM
02:30PM
02:23PM
Loading…
02:23PM
12:00PM
Apr-19-24 02:29PM
Apr-18-24 04:08PM
Apr-15-24 01:00PM
11:45AM
09:02AM
(The Wall Street Journal)
Apr-14-24 06:48AM
Apr-11-24 04:05PM
Apr-05-24 07:59AM
Apr-04-24 11:00AM
08:40AM
08:40AM
Apr-03-24 07:13PM
Apr-01-24 08:30AM
Mar-29-24 11:45AM
Mar-28-24 12:52PM
06:00AM
Mar-27-24 07:30AM
Mar-26-24 09:22AM
03:14AM
Mar-25-24 03:15PM
Mar-22-24 07:35AM
06:40AM
06:11AM
06:08AM
Mar-21-24 12:10PM
Mar-19-24 05:45PM
04:15AM
03:49AM
(The Wall Street Journal)
03:25AM
03:21AM
Mar-18-24 05:58AM
Mar-13-24 11:45AM
Mar-12-24 02:27PM
01:35PM
06:18AM
Mar-07-24 12:05AM
Mar-06-24 05:29AM
01:39AM
Mar-04-24 09:15AM
06:05AM
Mar-01-24 01:21PM
Feb-29-24 07:00AM
Feb-28-24 01:00AM
Feb-26-24 05:49PM
11:45AM
Feb-23-24 11:03AM
12:10AM
Feb-22-24 10:32AM
Feb-20-24 09:16PM
Feb-19-24 12:48PM
Feb-16-24 04:30AM
Feb-13-24 10:05AM
08:36AM
Feb-08-24 11:45AM
09:46AM
09:14AM
Feb-07-24 10:09PM
(Thomson Reuters StreetEvents) +8.64%
04:22PM
03:56PM
01:56PM
(The Wall Street Journal)
01:11PM
11:35AM
11:16AM
11:06AM
(The Wall Street Journal)
11:00AM
10:13AM
09:53AM
(The Wall Street Journal)
08:36AM
(Associated Press Finance)
The Carlyle Group, Inc. is a global investment firm. It operates through the following segments: Global Private Equity (GPE), Global Credit (GC), and Global Investment Solutions (GIS). The GPE segment focuses on buyout and growth capital funds, which pursue a variety of corporate investments of different sizes and growth potentials. The GC segment includes funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions, and global capital markets. The GIS segment provides comprehensive investment opportunities and resources for investors and clients to build private equity portfolios through fund of funds, secondary purchases or financings of existing portfolios, and managed co-investment programs. The company was founded by William Elias Conway Jr., Daniel Anthony D'Aniello, and David Mark Rubenstein in 1987 and is headquartered in Washington, DC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Carlyle Group Inc. Former 10% Owner Feb 08 '24 Buy 12.95 190,000 2,460,500 1,066,189 Feb 12 06:23 PM SCHWARTZ HARVEY M Chief Executive Officer Dec 15 '23 Sale 41.74 295,358 12,328,036 6,768,046 Dec 19 05:01 PM CG Subsidiary Holdings L.L.C. 10% Owner Sep 12 '23 Buy 8.52 1,269,537 10,816,455 4,785,628 Sep 14 04:05 PM CG Subsidiary Holdings L.L.C. 10% Owner Aug 28 '23 Buy 8.30 3,012,049 25,000,007 3,012,049 Aug 30 05:33 PM CG Subsidiary Holdings L.L.C. 10% Owner Aug 28 '23 Buy 8.30 504,042 4,183,549 504,042 Aug 30 05:33 PM Finn Christopher Chief Operating Officer Aug 02 '23 Sale 32.36 27,067 875,888 955,587 Aug 03 06:14 PM Buser Curtis L. Chief Financial Officer Aug 02 '23 Sale 32.36 25,828 835,794 1,221,416 Aug 03 06:13 PM Larson Bruce M. Chief Human Resources Officer Aug 02 '23 Sale 32.36 13,413 434,045 403,069 Aug 03 06:12 PM Ferguson Jeffrey W. General Counsel Aug 02 '23 Sale 32.36 11,939 386,346 1,182,891 Aug 03 06:08 PM Andrews Charles Elliott Jr. Chief Accounting Officer Aug 02 '23 Sale 32.36 6,669 215,809 84,745 Aug 03 06:09 PM Carlyle Group Inc. 10% Owner May 08 '23 Sale 86.12 2,000,000 172,250,000 6,482,732 May 10 04:37 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
